Regulatory guidance for industry to prepare for the UK’s withdrawal from the EU
EMA and the European Commission publish first in a series of Q&As for companies
The European Medicines Agency (EMA) and the European Commission have published guidance to help pharmaceutical companies to prepare for the United Kingdom's withdrawal from the European Union. The guidance relates to both human and veterinary medicines.
The questions-and–answers document concerns information related to the location of establishment of a company in the context of centralised procedures and certain activities, including the location of orphan designation holders, qualified persons for pharmacovigilance (QPPVs) and companies’ manufacturing and batch release sites.
EMA is preparing a series of further guidance documents which will be published on its website in due course. Companies are advised to regularly check EMA’s dedicated webpage on the consequences of Brexit.
This first questions-and-answers document follows the publication of the European Commission/EMA notice to marketing authorisation holders of centrally authorised medicines for human and veterinary use on 2 May 2017.
Latest News from
Council agrees on emergency measures to reduce energy prices03/10/2022 16:33:00
EU energy ministers recently (30 September 2022) reached a political agreement on a proposal for a Council Regulation to address high energy prices.
Guidelines on general visa issuance in relation to Russian applicants and controls of Russian citizens at the external borders03/10/2022 15:25:00
The Commission recently (30 September 2022) presented updated guidelines to Member States on visa procedures as well as on border controls for Russian citizens at the EU's external borders.
Message of President Charles Michel on Russia's illegal annexation of Ukrainian regions03/10/2022 14:33:00
Message of President Charles Michel on Russia's illegal annexation of Ukrainian regions (30 September 2022).
Ethiopia: Statement by Commissioner Lenarčič on the humanitarian situation and International Humanitarian Law in northern Ethiopia03/10/2022 13:25:00
Ethiopia: Statement given recently (30 September 2022) by Commissioner Lenarčič on the humanitarian situation and International Humanitarian Law in northern Ethiopia.
Antitrust: Commission upgrades eLeniency tool to grant companies online access to leniency and settlement documents03/10/2022 12:10:00
The European Commission has upgraded its online platform “eLeniency” to ensure that companies who are parties to cartel and antitrust proceedings can easily and securely access documents online.
State aid: Commission approves aid to support the resolution of the Polish Getin Noble Bank S.A.03/10/2022 11:33:00
The European Commission has approved, under EU State aid rules, several support measures in the context of the resolution of the Polish Getin Noble Bank S.A.
Council and Parliament reach provisional political agreement on access to Union waters, extending the current rules for fishermen for another ten years30/09/2022 15:25:00
The Czech Presidency of the Council of the European Union and the European Parliament reached a provisional political agreement as regards the regime for access of fishing vessels to member states’ territorial waters.
Ensuring radiation protection: Commission refers LATVIA to Court to guarantee citizens' protection from ionising radiation-exposure risks30/09/2022 14:33:00
The Commission is taking legal steps to ensure the protection of citizens, workers and patients against the dangers arising from exposure to ionizing radiation.
Investor citizenship scheme: Commission refers MALTA to the Court of Justice30/09/2022 13:25:00
The European Commission yesterday decided to refer Malta to the Court of Justice of the European Union for its investor citizenship scheme, also referred to as the ‘golden passports'.
Human rights: EU increases support to the protection of human rights defenders worldwide30/09/2022 12:38:00
Human rights are increasingly under threat worldwide. Against this global backdrop, reconfirming the European Union's strong support to human rights, fundamental freedoms and democracy, and their defenders worldwide, Commissioner Jutta Urpilainen yesterday signed €30 million, a substantial increase, for the new phase of the EU Human Rights Defenders Mechanism, in the presence of civil society organisations and human rights defenders, for the period 2022–2027.